BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34618750)

  • 1. Brain Metastases in Patients With Soft-Tissue Sarcomas: Management and Survival-A SEER Population-Based Cohort Study.
    Gonzalez MR; Bryce-Alberti M; Leon-Abarca JA; Pretell-Mazzini J
    J Am Acad Orthop Surg Glob Res Rev; 2021 Oct; 5(10):. PubMed ID: 34618750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcoma brain metastases: Tertiary cancer center experience.
    Ababneh HS; Muhsen B; Fares AS; Hirbawi H; Awabdeh TA; Hussaini MA; Amarin R; Mousa AA; Salah S
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S758-S763. PubMed ID: 38384052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO).
    Chaigneau L; Patrikidou A; Ray-Coquard I; Valentin T; Linassier C; Bay JO; Moureau Zabotto L; Bompas E; Piperno-Neumann S; Penel N; Alcindor T; Laigre M; Guillemet C; Salas S; Hugli A; Domont J; Sunyach MP; Lecesne A; Blay JY; Nerich V; Isambert N
    Oncologist; 2018 Aug; 23(8):948-955. PubMed ID: 29934413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in patients with carcinomas presenting with bone metastasis at diagnosis: a SEER population-based cohort study.
    Younis MH; Fuentes-Rivera L; Summers S; Pretell-Mazzini J
    Arch Orthop Trauma Surg; 2021 Mar; 141(3):367-373. PubMed ID: 32236712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group.
    Malouf GG; Beinse G; Adam J; Mir O; Chamseddine AN; Terrier P; Honore C; Spano JP; Italiano A; Kurtz JE; Coindre JM; Blay JY; Le Cesne A
    Oncologist; 2019 Jul; 24(7):980-988. PubMed ID: 30626710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synovial Sarcoma Is Not Associated With a Higher Risk of Lymph Node Metastasis Compared With Other Soft Tissue Sarcomas.
    Jacobs AJ; Morris CD; Levin AS
    Clin Orthop Relat Res; 2018 Mar; 476(3):589-598. PubMed ID: 29529647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of homogeneous and heterogeneous risk factors on the incidence and prognosis of brain metastases in patients with hepatocellular carcinoma.
    Lin X; Zhang P; Huang R; Huang Y; Sun J; Zheng H; Tian X; Wang X
    Ann Palliat Med; 2020 Sep; 9(5):2654-2667. PubMed ID: 32921091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Outcome of the Patients With Brain Metastasis from Soft Tissue Sarcomas.
    Takemori T; Kawamoto T; Morishita M; Hara H; Fukase N; Kawakami Y; Fujiwara S; Kitayama K; Yahiro S; Miyamoto T; Fujimoto T; Fujita I; Mifune Y; Hoshino Y; Kakutani K; Matsumoto T; Matsushita T; Niikura T; Kuroda R; Akisue T
    Anticancer Res; 2021 Feb; 41(2):1027-1034. PubMed ID: 33517311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and survival outcomes of synchronous and metachronous brain metastases: a retrospective population-based study.
    Jiang K; Parker M; Materi J; Azad TD; Kamson DO; Kleinberg L; Ye X; Rincon-Torroella J; Bettegowda C
    Neurosurg Focus; 2023 Aug; 55(2):E3. PubMed ID: 37527669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
    Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
    Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective analysis of the prognosis of Japanese patients with sarcoma brain metastasis.
    Toda Y; Kobayashi E; Kubota D; Miyakita Y; Narita Y; Kawai A
    Cancer Med; 2023 Apr; 12(8):9471-9481. PubMed ID: 36811144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of Thrombomodulin mRNA in High-Grade Soft Tissue Sarcomas after 10 years.
    Asanuma K; Nakamura T; Asanuma Y; Okamoto T; Kakimoto T; Yada Y; Hagi T; Kita K; Nakamura K; Matsumine A; Sudo A
    Orthop Surg; 2020 Dec; 12(6):1726-1732. PubMed ID: 33015987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data.
    Goncalves PH; Peterson SL; Vigneau FD; Shore RD; Quarshie WO; Islam K; Schwartz AG; Wozniak AJ; Gadgeel SM
    Cancer; 2016 Jun; 122(12):1921-7. PubMed ID: 27062154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal Increase in Survival Throughout the Years in Patients with Soft Tissue Sarcoma with Synchronous Metastases: Results of a Population-Based Study.
    Vos M; Ho VKY; Oosten AW; Verhoef C; Sleijfer S
    Oncologist; 2019 Jul; 24(7):e526-e535. PubMed ID: 30190301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soft tissue sarcoma brain metastases. Prevalence in a cohort of 3829 patients.
    Espat NJ; Bilsky M; Lewis JJ; Leung D; Brennan MF
    Cancer; 2002 May; 94(10):2706-11. PubMed ID: 12173340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
    Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
    BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
    Lindner LH; Litière S; Sleijfer S; Benson C; Italiano A; Kasper B; Messiou C; Gelderblom H; Wardelmann E; Le Cesne A; Blay JY; Marreaud S; Hindi N; Desar IME; Gronchi A; van der Graaf WTA
    Int J Cancer; 2018 Jun; 142(12):2610-2620. PubMed ID: 29383713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone metastasis in extremity soft tissue sarcomas: risk factors and survival analysis using the SEER registry.
    Younis MH; Summers S; Pretell-Mazzini J
    Musculoskelet Surg; 2022 Mar; 106(1):59-68. PubMed ID: 32638225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curability of patients with lymph node metastases from extremity soft-tissue sarcoma.
    Basile G; Mattei JC; Alshaygy I; Griffin AM; Catton CN; Chung PW; Shultz DB; Razak ARA; Demicco EG; Ferguson PC; Wunder JS
    Cancer; 2020 Dec; 126(23):5098-5108. PubMed ID: 32910462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative brain metastases in soft tissue sarcomas.
    Urakawa H; Tsukushi S; Kozawa E; Ikuta K; Hamada S; Ishiguro N; Nishida Y
    Clin Exp Metastasis; 2015 Apr; 32(4):345-51. PubMed ID: 25795392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.